Recombinant Human Annexin A5, PE

• Cat.No.: ANXA5-2626H
• Product Overview: Recombinant Human Annexin A5-PE is expressed inE. coli.

Specification

• Cat. No.: ANXA5-2626H
• Description: Annexin 5 is a member of the annexin family of calcium-dependent phospholipid binding proteins. Annexin 5 is a phospholipase A2 and protein kinase C inhibitory protein with calcium channel activity and a potential role in cellular signal transduction, inflammation, growth and differentiation. In vitro studies have shown that Annexin 5 is a cellular protein which plays a role in the inhibition of blood coagulation by competing for phosphatidylserine binding sites with prothrombin. Through affinity assays Annexin 5 has been localized on cells that expressed phosphatidylserine on the cell surface, a feature found in apoptosis as well as other forms of cell death.
• Source: E. coli.
• Purity: >98% pure as demonstrated by SDS-gel electrophoresis and reverse phase HPLC.
• Molecular Weight: 35.8 kDa.
• Presentation: Solution containing 50 mM TRIS, 100 mM NaCl, 1% BSA, 0.02% Sodium Azide, pH 7.4.
• Biological Activity: Annexin V exhibits anti-phospholipase activity and binds to phosphatidylserine (PS).
• Application: PE labelling allows simple direct detection of PS by FACS analysis. Counterstaining by propidium iodide allows the discrimination of apoptotic cells.
• Storage: Stable at 2°-8°C as indicated on the label. Do not freeze!

Gene Information

• Gene Name: ANXA5 annexin A5 [ Homo sapiens ]
• Synonyms:
  ANXA5; annexin A5; PP4; ANX5; ENX2; anchorin CII; endonexin II; lipocortin V; placental anticoagulant protein I; Annexin-5; Annexin V; Lipocortin V; Endonexin II; Calphobindin I; Placental anticoagulant protein I; Placental anticoagulant protein 4; Thromboplastin inhibitor; Vascular anticoagulant-alpha; VAC-alpha; CBP-I; PAP-I
• Gene ID: 308
• mRNA Refseq: NM_001154
• Protein Refseq: NP_001145
• MIM: 131230
• UniProt ID: P08758
• Chromosome Location: 4q27
• Function: calcium ion binding; calcium-dependent phospholipid binding; eukaryotic cell surface binding; phospholipase inhibitor activity; protein binding; receptor tyrosine kinase binding